Nicotinic acid and catechol-O-methyl-transferase activity in schizophrenia.
D002394:Catechol O-Methyltransferase / Q000097:blood / Q000378:metabolism; D004347:Drug Interactions; D006213:Hallucinogens / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D006801:Humans; D008715:Methionine / Q000008:administration & dosage; D008745:Methylation; D008780:Methyltransferases / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000378:metabolism; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000378:metabolism*; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*; D014191:Tranylcypromine / Q000008:administration & dosage
D006213:Hallucinogens; D008996:Monoamine Oxidase Inhibitors; D009539:Nicotinic Acids; D010919:Placebos; D014191:Tranylcypromine; D008715:Methionine; D008780:Methyltransferases; D002394:Catechol O-Methyltransferase